article thumbnail

Non-fluoroscopic vs. fluoroscopic radiofrequency catheter ablation for pediatric atrioventricular nodal reentrant tachycardia: a comparative study of procedural characteristics and ablation site

Frontiers in Cardiovascular Medicine

BackgroundNon-fluoroscopic cryoablation is considered safe for pediatric atrioventricular nodal reentrant tachycardia (AVNRT), but concerns about prolonged procedures and recurrence persist, requiring continued use of radiofrequency ablation (RFA). Non-fluoroscopic RFA, guided by three-dimensional mapping, offers enhanced precision.

article thumbnail

Clinical characteristics and mortality risk factors in pediatric hypertrophic, restrictive, and rapidly progressive hypertrophic cardiomyopathy: a retrospective cohort study with follow-up

Frontiers in Cardiovascular Medicine

ConclusionsThis study underscores the importance of early diagnosis, genetic testing, and integrated management in pediatric cardiomyopathies. Only 10.4% (22/212) of patients underwent genetic testing, yet the positive detection rate was 63.7% (14/22).ConclusionsThis

article thumbnail

Left Atrial Stiffness Is Increased in Pediatric Hypertrophic Cardiomyopathy and Offers Incremental Value in Predicting Major Adverse Cardiac Events in This Group

Journal of the American Heart Association

BackgroundDetermining risk factors by echocardiography to prevent major adverse cardiac events (MACE) is crucial in pediatric patients with hypertrophic cardiomyopathy. ConclusionsLA stiffness is a newly described index, which may be of incremental value in predicting risk of MACE in pediatric patients with hypertrophic cardiomyopathy.

article thumbnail

Successful interventional closure of patent ductus arteriosus in three pediatric cases with congenital heart disease and severe pulmonary hypertension: a case series and literature review

Frontiers in Cardiovascular Medicine

Case characteristics and therapeutic strategies were analyzed in conjunction with the literature.ResultsAll three pediatric patients had CHD combined with severe PH and underwent successful PDA occlusion after administration of at least 3 months of endothelin receptor antagonist or PDE5 inhibitor therapy (targeted therapy).

article thumbnail

Artificial intelligence-assisted echocardiographic monitoring in pediatric patients on extracorporeal membrane oxygenation

Frontiers in Cardiovascular Medicine

BackgroundPercutaneous extracorporeal membrane oxygenation (ECMO) is administered to pediatric patients with cardiogenic shock or cardiac arrest. Additionally, raw data images of apical 2-chamber and 4-chamber views were utilized for EF assessment via a Pediatric ECMO Quantification machine learning-enabled AI (automated-EF).ResultsThere

article thumbnail

CareDx Launches Two Expanded Indications for AlloSure Testing Services

DAIC

The Transplant Company recently announced that AlloSureis now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 1 "The availability of AlloSure dd-cfDNA for all pediatric heart transplant patients is a major development.

article thumbnail

FDA Expands Indication for Impella Heart Pumps for Pediatric Patients

DAIC

12, 2024 Physicians have a new treatment option for many of the sickest pediatric patients with heart failure andcardiogenic shock. and Impella CP, both left-sided heart pumps, for pediatric patients with symptomatic ADHF and cardiogenic shock. with SmartAssist tim.hodson Wed, 12/18/2024 - 14:06 Dec.